Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$124.79 USD
-2.42 (-1.90%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $124.89 +0.10 (0.08%) 7:48 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Earnings News For SRPT
-
Why Is Sarepta Therapeutics (SRPT) Down 1.9% Since Last Earnings Report?
-
Sarepta (SRPT) Q2 Earnings Top Estimates, Sales Lag, View Weak
-
Sarepta Therapeutics: Q2 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) Down 4.7% Since Last Earnings Report: Can It Rebound?
-
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
-
Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
-
Sarepta Therapeutics: Q1 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
-
Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y
-
Sarepta Therapeutics: Q4 Earnings Snapshot
-
Sarepta (SRPT) to Report Q4 Earnings: Will It Beat Estimates?
-
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2023 Net Product Revenue
-
Sarepta Therapeutics (SRPT) Up 4.5% Since Last Earnings Report: Can It Continue?
-
Sarepta (SRPT) Q3 Loss Narrower Than Expected, Sales Beat
-
Sarepta Therapeutics: Q3 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Sarepta Therapeutics (SRPT) Up 12.7% Since Last Earnings Report: Can It Continue?
-
Sarepta (SRPT) Q2 Loss Narrower Than Expected, Sales Miss
-
Sarepta Therapeutics (SRPT) Reports Q2 Loss, Misses Revenue Estimates
-
Sarepta Therapeutics: Q2 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
Why Is Sarepta Therapeutics (SRPT) Down 1.5% Since Last Earnings Report?
-
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
-
Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates